Imagine a world where genetic diseases are treated with orally-available small molecule drugs. That's the future Sharp Edge Labs is building. Sharp Edge is a preclinical-stage life sciences company developing drugs for genetic diseases. Our monogenic disease focus de-risks the clinical path. Each pipeline program has a genetically identifiable subset of patients and an early Phase IB pharmacodynamic readout.
We combine three core techologies to create a scalable platform for discovery and development. CoreX(tm) is s suite of assay technologies that enable the creation of realistic cellular models of genetic diseases. AlloChem(tm) is a proprietary compound library computationally biased to contain molecules that can bind proteins allosterically, stabilizing them, and restoring their function. Disco/Mine(tm) is a suite of computational and machine learning tools that enhances our experimental approach rather than replacing it. These combine to create a scalable platform with over 10 programs at various stages of development.
The company has programs in Frontotemporal Dementia, and genetic subsets of Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders and other loss-of-function diseases.
The team and its advisors includes ex and current Genzyme/Sanofi, Synageva, Pfizer and Shire executives.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 2403 Sidney Street, Suite 264, Pittsburgh,pa 15203,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.sharptx.com
- Keywords
- Drug Discovery and Genetic Diseases.
- HQ
- Pittsburgh, PA
Sharp Therapeutics Questions
Sharp Therapeutics's website is http://www.sharptx.com
Sharp Therapeutics's LinkedIn profile is https://www.linkedin.com/company/sharp-therapeutics
Sharp Therapeutics has
11 employees.
View email and phone details for 11
employees at Sharp Therapeutics.
Sharp Therapeutics's industry is
Biotechnology Research
Sharp Therapeutics's top competitors are
Carna Health,
Ariel Precision Medicine,
Beam Therapeutics,
Satellos Bioscience,
Polyphotonix,
Takeda,
Diamune Therapeutics,
Versabank,
Vyome Therapeutics, Inc.,
Noveome Biotherapeutics, Inc..
Sharp Therapeutics's categories are Biotechnology Research
Sharp Therapeutics's founding year is 2010
